CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
CTS Spotlight at 2018 AABB Annual Meeting Sunday, October 14, 2018 at 1:30 PM: Scientific Oral ...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...